Abstract
In this report, the authors present a detailed immunological and virological assessment of an immunocompetent 17-year-old Caucasian male with a fatal Epstein-Barr virus (EBV) infectious mononucleosis presenting with meningoencephalitis and hemophagocytic syndrome. The patient with serologically confirmed EBV infectious mononucleosis was admitted to the hospital because of 3 weeks’ fever. Fine-needle aspiration of lymph nodes showed reactive hyperplasia with prominent hemophagocytosis. Percentages of intracellular interferon-gamma (IFN-γ) in CD4+ and CD8+ T cells in the peripheral blood progressively increased during the course of disease (10.2% and 8.5% on day 35; 30.1% and 53.2% on day 44; 42.2% and 75.2% on day 50; 36.1% and 50.6% on day 59, respectively). On day 50, the patient developed meningoencephalitis. Brain computed tomography (CT) was normal. Brain magnetic resonance imaging (MRI) showed multifocal inflammatory lesions in frontal and temporal cortex of the right hemisphere as well as severe perivascular inflammatory reaction. The patient was treated with steroids, cyclosporin A, and methotrexate intratecally. Following treatment, EBV viremia in the blood and cerebrospinal fluid (CSF) decreased from pretreatment values (54,490 copies of EBV DNA/ml and 39,500 copies/ml, respectively) to 8715 copies/ml in the blood and 14,690 in the CSF. Despite treatment, the patient remained unconscious and died of sepsis and pneumonia 3 months after initial symptoms. Immunohistochemical staining showed the presence of EBV in both perivascular infiltrates and grey matter. Enhanced Th1 response as shown by high levels of IFN-γ in peripheral blood lymphocytes may be a predictor of severe complications during acute EBV infection. Early implementation of immunosuppressive therapy in these patients should be considered.
Similar content being viewed by others
References
Attarbaschi T, Willheim M, Ramharter M, Hofmann A, Wahl K, Winkler H, Graninger W, Winkler S (2003). T cell cytokine profile during primary Epstein-Barr virus infection (infectious mononucleosis). Eur Cytokine Netw 14: 34–39.
Christensen T (2006). The role of EBV in MS pathogenesis. Int Mult Scler J 13: 52–57.
Doja A, Bitnun A, Jones EL, Richardson S, Tellier R, Petric M, Heurter H, Macgregor D (2006). Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol 21: 385–391.
Drebber U, Kasper HU, Krupacz J, Haferkamp K, Kern MA, Steffen HM, Quasdorff M, zur Hausen A, Odenthal M, Dienes HP (2006). The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol 44: 879–885.
Francisci D, Sensini A, Fratini D, Moretti MV, Luchetta ML, Di Caro A, Stagni G, Baldelli F (2004). Acute fatal necrotizing hemorrhagic encephalitis caused by Epstein-Barr virus in a young adult immunocompetent man. J Neuro Virol 10: 414–417.
Hinedi TB, Koff RS (2003). Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 48: 539–541.
Hiroshima K, Iyoda A, Isobe K, Ishii G, Toyozaki T, Shibuya K, Shimamura F, Haga Y, Okimoto Y, Horie H, Harigaya K, Ohwada H (2003). Fatal infectious mononucleosis with evidence suggestive of the developmenot of B cell lymphoma. Pathol Int 53: 642–648.
Hislop AD, Annels NE, Gudgeon NH, Leese AM, Rickinson AB (2002). Epitope-specific evolution of human CD8+ T cell responses from primary to persistent phases of Epstein-Barr virus infection. J Exp Med 195: 893–905.
Holmoy T, Kvale EO, Vartdal F (2004). Cerebrospinal fluid CD4+ T cells from a multiple sclerosis patients cross-recognize Epstein-Barr virus and myelin basic protein. J NeuroVirol 10: 278–283.
Imashuku S (2002). Clinical features and treatment strategies of Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis. Crit Rev Oncol Hematol 44: 259–272.
Kasahara Y, Yachie A, Takei K, Kanegane C, Okada K, Ohta K, Seki H, Igarashi N, Maruhashi K, Katayama K, Katoh E, Terao G, Sakiyama Y, Koizumi S (2001). Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection. Blood 98: 1882–1888.
Khamma S, Kumar A (2003). Infectious mononucleosis presenting as acute hepatitis, with marked leukocytosis and renal involvement. Indian J Gastroenterol 22: 62.
Kivisakk P, Trebst C, Liu Z, Tucky BH, Sorensen TL, Rudick RA, Mack M, Ransohoff RM. (2002). T cells in the cerebrospinal fluid express a similar repertoire of inflammatory chemokine receptors in the absence or presence of CNS inflammation: implications for CNS trafficking. Clin Exp Immunol 129: 510–518.
Kobbervig C, Norback D, Kahl B (2003). Infectious mononucleosis progressing to fatal malignant lymphoma: a case report and review of the literature. Leuk Lymphoma 44: 1215–1221.
Kumakura S (2005). Hemophagocytic syndrome. Intern Med 4: 278–280.
Lay JD, Tsao CJ, Chen JY, Kadin ME, Su IJ (1997). Up-regulation of tumor necrosis factor-α gene by Epstein-Barr virus and activation of macrophages in Epstein-Barr virus-infected T cells in the pathogenesis of hemophagocytic syndrome. J Clin Invest 100: 1969–1979.
Lehrnbecher T, Chittka B, Nanan R, Seidenspinner S, Kreth HW, Schuster V (1996). Activated T lymphocytes in the cerebrospinal fluid of a patient with Epstein-Barr virus-associated meningoencephalitis. Pediatr Infect Dis 15: 631–363.
Majid A, Galetta SL, Sweeney CJ, Robinson C, Mahalingam R, Smith J, Forghani B, Gliden DH (2002). Epstein-Barr virus myeloradiculitis and encephalomyeloradiculitis. Brain 125: 159–165.
Markin RS (1994). Manifestations of Epstein-Barr virus-associated disorders in liver. Liver 14: 1–13.
Merelli E, Bedin R, Sola P, Gentilini M, Pietrosemoli P, Meacci M, Portolani M (1997). Encephalomyeloradiculopathy associated with Epstein-Barr virus: primary infection or reactivation? Acta Neurol Scand 96: 416–420.
Mizuno I, Takanashi Y, Onodera H, Shigeta M, Tanaka N, Yuya H, Kitaichi M, Nakajima K (2003). A case of lymphomatoid granulomatosis/angiocentric immunoproliferative lesions with long clinical course and diffuse brain involvement. J Neurol Sci 213: 67–76.
Negro F (2006). The paradox of Epstein-Barr virus-associated hepatitis. J Hepatol 44: 839–841.
Neuenburg JK, Cho TA, Nilsson A, Bredt BM, Hebert SJ, Grant RM, Price RW (2005). T-cell activation and memory phenotypes in cerebrospinal fluid during HIV infection. J Acquir Immune Defic Syndr 39: 16–22.
Pelletier LL, Borel DM, Romig DA, Liu C (1976). Disseminated intravascular coagulation and hepatic necrosis. Complications of infectious mononucleosis. JAMA 235: 1144–1146.
Riemer G, Stenvik O, Dahl OP, Slungaard S, Ringstad J, Bruu AL (2001). Encephalitis after acute Epstein-Barr virus infection. Tidsskr Nor Laegeforen 121: 1798–1800.
Sato S, Kawashima H, Oshiro H, Hasegawa D, Kashiwagi Y, Takekuma K, Hoshika A (2004). Virological and immunological characteristics of a 19-year-old Japanese female with fatal outcome with Epstein-Barr virus-associated hemophagocytic syndrome. J Clin Virol 31: 235–238.
Schellinger PD, Sommer C, Leithauser F, Schwab S, Storch-Hagenlocher B, Hacke W, Kiessling M (1999). Epstein-Barr virus meningoencephalitis with a lymphoma-like response in an immunocompetent host. Ann Neurol 45: 659–662.
Tselis A, Duman R, Storch GA, Lisak RP (1997). Epstein-Barr virus encephalomyelitis diagnosed by polymerase chain reaction: detection of the genome in the CSF. Neurology 48: 1351–1353.
Yamashita S, Murakami C, Izumi Y, Sawada H, Yamazaki Y, Yokota TA, Matsumoto N, Matsukura S (1998). Severe chronic active Epstein-Barr virus infection accompanied by virus-associated hemophagocytic syndrome, cerebellar ataxia and encephalitis. Psychiatry Clin Neurosci 52: 449–452.
Zephir H, De Seze J, Ferriby D, Stojkovic T, Vermersch P (2002). Epstein-Barr meningoencephaloradiculitis in a immunocompetent woman. Rev Neurol 158: 830–832.
Židovec Lepej S, Vince A, Dakovic Rode O, Remenar A, Jeren T (2003). Increased numbers of CD38 molecules on bright CD8+ T lymphocytes in infectious mononucleosis caused by Epstein-Barr virus infection. Clin Exp Immunol 133: 384–390.
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was supported by grants from the Croatian Ministry of Science, Education and Sports to Dr. Vince and Dr. Židovec Lepej (grants number 143-1080116-0097 and 143-0000000-0117).
Rights and permissions
About this article
Cite this article
Vince, A., Lepej, S.Ž., Kurelac, I. et al. Virological and immunological characteristics of fatal Epstein-Barr virus mononucleosis in a 17-year-old Caucasian male presenting with meningoencephalitis and hemophagocytic syndrome. Journal of NeuroVirology 13, 389–396 (2007). https://doi.org/10.1080/13550280701447042
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280701447042